Comparative efficacy and tolerability of two sustained-release formulations of diclofenac: Results of a double-blind, randomised study in patients with osteoarthritis and a reappraisal of diclofenac's use in this patient population

Current Medical Research and Opinion

Volumn 23, Issue 8, 2007, Pages 1957-1966

  Wagenitz, Andreas ^a,d   Mueller, Edgar A ^b   Frentzer, Adrian ^c   Cambon, Nathalie ^c  

^a Clinical Practice for Orthopaedics   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c Mepha Ltd   (Switzerland)

^d Praxis für Orthopádie ^*  (Germany)

Author keywords

Analgesia; Diclofenac; Non inferiority analysis; NSAID; Osteoarthritis; Sustained release

Indexed keywords

DICLOFENAC;

ABDOMINAL PAIN; ADULT; AGED; ANALGESIC ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; DRUG USE; DRUG WITHDRAWAL; FATIGUE; FEMALE; FLATULENCE; HEADACHE; HEMATOCHEZIA; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NAUSEA; OSTEOARTHRITIS; PAIN ASSESSMENT; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; SUSTAINED DRUG RELEASE; TREATMENT DURATION; TREATMENT OUTCOME; UPPER ABDOMINAL PAIN; VISUAL ANALOG SCALE;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; DOSAGE FORMS; DOUBLE-BLIND METHOD; HUMANS; MIDDLE AGED; OSTEOARTHRITIS; TREATMENT OUTCOME;

EID: 34548118265     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079907X223251     Document Type: Article

References (38)

1. Hunter DJ, Felson DT. Osteoarthritis. Br Med J 2006;332:639-42
2. Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Ann Rev Pharmacol Toxicol 1998;38:97-120
3. Kean WF, Buchanan WW. The use of NSAIDs in rheumatic disorders 2005: a global perspective. Inflammopharmacology 2005;13:343-70
4. Mukherjee D, Topol EJ. Cox-2: where are we in 2003? - cardiovascular risk and Cox-2 inhibitors. Arthritis Res Ther 2003;5:8-11
5. Rodriguez LA, Patrignani P. The ever growing story of cyclooxygenase inhibition. Lancet 2006;368:1745-7
6. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000;43:1905-15
7. Jordan KM, Arden NK, Doherty M, et al. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003;62:1145-55
8. Zhang W, Doherty M, Arden N, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2005;64:669-81
9. Steinmeyer J, Konttinen YT. Oral treatment options for degenerative joint disease - present and future. Adv Drug Deliv Rev 2006;58:168-211
10. Langman MJ, Weil J, Wainwright P, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:1075-8
11. Altman R. International experience with diclofenac in osteoarthritis. Am J Med 1986;80(Suppl. 4B):48-52
12. Ward JR. Efficacy of diclofenac in osteoarthritis. Experience in the United States. Am J Med 1986;80(Suppl. 4B):53-7
13. Bakshi R. Comparative efficacy and tolerability of two diclofenac formulations in the treatment of painful osteoarthritis. Br J Clin Pract 1996;50:294-7
14. Akhtar NM, Naseer R, Farooqi AZ et al. Oral enzyme combination versus diclofenac in the treatment of osteoarthritis of the knee - a double-blind prospective randomized study. Clin Rheumatol 2004;23:410-5
15. Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rheum Dis 1957;16:494-502
16. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24
17. Schattenkirchner M, Milachowski KA. A double-blind, multicentre, randomised clinical trial comparing the efficacy and tolerability of aceclofenac with diclofenac resinate in patients with acute low back pain. Clin Rheumatol 2003;22:127-35
18. Zacher J, Feldman D, Gerli R, et al. A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis. Curr Med Res Opin 2003;19:725-36
19. Le Loet X, Dreiser RL, Le Gros V, Febvre N. Therapeutic equivalence of diclofenac sustained-released 75 mg tablets and diclofenac enteric-coated 50 mg tablets in the treatment of painful osteoarthritis. Int J Clin Pract 1997;51:389-93
20. Schubiger BI, Ciccolunghi SN, Tanner K. Once daily dose treatment with a non-steroidal anti-rheumatic drug (diclofenac) in osteoarthrosis. J Int Med Res 1980;8:167-74
21. Marenco JL, Perez M, Navarro FJ, et al. A multicentre, randomised, double-blind study to compare the efficacy and tolerability of dexketoprofen trometamol versus diclofenac in the symptomatic treatment of knee osteoarthritis. Clin Drug Investig 2000;19:247-56
22. Scheidel B, Blume H, Walter K, et al. Biological availability of gastric juice-resistant coated diclofenac preparations. 1. Bioavailability study following a single administration of a multiple-unit formulation in comparison with a single-unit formulation. Arzneimittelforschung/Drug Res 1993;43:1211-5
23. Nishihata T, Sudho M, Kamada A, et al. Investigation of sustained-release suppository of sodium diclofenac in humans. Int J Pharm 1986;33:181-6
24. Goei The HS, Lund B, Distel MR, Bluhmki E. A double-blind, randomized trial to compare meloxicam 15 mg with diclofenac 100 mg in the treatment of osteoarthritis of the knee. Osteoarthritis Cartilage 1997;5:283-8
25. Skeljo MV, Giraud AS, Yeomans ND. Gastric mucosal damage induced by nonsalicylate nonsteroidal antiinflammatory drugs in rats is mediated systemically. Dig Dis Sci 1993;38:2038-42
26. Towheed T, Shea B, Wells G, Hochberg M. Analgesia and non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the hip. Cochrane Database Syst Rev 2000;2:CD000517
27. Bjordal JM, Ljunggren AE, Klovning A, Slordal L. Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials. Br Med J 2004;329:1317-20
28. NSAIDs for treating Osteoarthritis. Bandolier 1999; http://www.jr2.ox.ac. uk/bandolier/booth/painpag/Chronrev/OARA/OANSAID.html [accessed 18 December 2006]
29. Deeks JJ, Smith LA, Bradley MD. Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials. Br Med J 2002;325:619-23
30. Rostom A, Dube C, Jolicoeur E, et al. Gastroduodenal ulcers associated with the use of non-steroidal anti-inflammatory drugs: a systematic review of preventive pharmacological interventions. Ottawa: Canadian Coordinating Office for Health Technology Assessment; 2004 [Technology overview 12]
31. Spiegel BM, Chiou CF, Ofman JJ. Minimizing complications from nonsteroidal antiinflammatory drugs: cost-effectiveness of competing strategies in varying risk groups. Arthritis Rheum 2005;53:185-97
32. Kearney PM, Baigent C, Godwin J, et al. Do selective cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. Br Med J 2006;332:1302-8
33. Solomon DH, Avorn J, Sturmer T, et al. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Arthritis Rheum 2006;54:1378-89
34. Watson MC, Brookes ST, Kirwan JR, Faulkner A. Non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the knee. Cochrane Database Syst Rev 2000;2:CD000142
35. Wolfe F, Zhao S, Lane N. Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Arthritis Rheum 2000;43:378-85
36. Pincus T, Swearingen C, Cummins P, Callahan LF. Preference for nonsteroidal antiinflammatory drugs versus acetaminophen and concomitant use of both types of drugs in patients with osteoarthritis. J Rheumatol 2000;27:1020-7
37. Bannwarth B. Acetaminophen or NSAIDs for the treatment of osteoarthritis. Best Pract Res Clin Rheumatol 2006;20:117-29
38. Dougados M. Why and how to use NSAIDs in osteoarthritis. J Cardiovasc Pharmacol 2006;47(Suppl 1):S49-S54